• Ping An Biomedical will hold an extraordinary general meeting in Hong Kong on October 29, 2026.
• Shareholders will vote to ratify a 40-for-1 consolidation of class A and class B ordinary shares, effective October 23, 2026.
• Another proposal would increase authorized share capital from USD 312,500 to USD 12.5 million.
• Further proposed share consolidations range from 10-for-1 to 80-for-1, depending on class A ordinary share closing prices below USD 1.
• Related amendments to the memorandum and articles of association will also be put to shareholders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-111735), on October 22, 2026, and is solely responsible for the information contained therein.